Displaying drugs 14601 - 14625 of 15249 in total
Budigalimab
Budigalimab is under investigation in clinical trial NCT04807972 (Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 Is Administered in Combination With IV Modified FOLFIRINOX (Mffx) With or Without IV Budigalimab Compared to Mffx in Adult Participants With Untreated Pancreatic Cancer Metastasis).
Investigational
Matched Description: … Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 Is Administered in Combination ... Budigalimab is under investigation in clinical trial NCT04807972 (Study to Evaluate Adverse Events and ... With IV Modified FOLFIRINOX (Mffx) With or Without IV Budigalimab Compared to Mffx in Adult Participants …
Nafithromycin
Nafithromycin is under investigation in clinical trial NCT02903836 (Phase II Study of Oral Nafithromycin in CABP).
Investigational
Matched Iupac: … (Z,3R,3aS,4R,6R,8R,9R,10R,12R,15R,15aS)-9-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2- …
Matched Description: … in CABP). ... Nafithromycin is under investigation in clinical trial NCT02903836 (Phase II Study of Oral Nafithromycin …
Matched Description: … in CABP). ... Nafithromycin is under investigation in clinical trial NCT02903836 (Phase II Study of Oral Nafithromycin …
BTA798
BTA798 is an antiviral for the treatment of HRV, the common cold virus, known to cause significant clinical complications in sufferers of Asthma and Chronic Obstructive Pulmonary Disease.
Investigational
Matched Description: … for the treatment of HRV, the common cold virus, known to cause significant clinical complications in …
Cobiprostone
Investigational
Cantuzumab ravtansine
Investigational
Dextrin 2-sulfate
Investigational
Epelsiban
Epelsiban has been investigated for the treatment of Premature Ejaculation.
Investigational
Matched Iupac: … 6-[(2S)-butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2,6-dimethylpyridin-3-yl)-2-(morpholin-4- …
Lactoferrin
Lactoferrin is under investigation in clinical trial NCT03748043 (The Effectiveness of Lactoferrin in Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis).
Investigational
Matched Description: … Lactoferrin is under investigation in clinical trial NCT03748043 (The Effectiveness of Lactoferrin in ... Treatment of Iron Deficiency Anemia in Children With Chronic Tonsillitis). …
Barusiban
Barusiban has been used in trials studying the treatment of Infertility and In Vitro Fertilisation (IVF) Treatment.
Investigational
Matched Iupac: … -16-[(1H-indol-3-yl)methyl]-N-methyl-6,9,12,15,18-pentaoxo-1-thia-5,8,11,14,17-pentaazacycloicosane-4- …
Matched Description: … Barusiban has been used in trials studying the treatment of Infertility and In Vitro Fertilisation (IVF …
Matched Description: … Barusiban has been used in trials studying the treatment of Infertility and In Vitro Fertilisation (IVF …
Vobarilizumab
Vobarilizumab is under investigation in clinical trial NCT02101073 (ALX-0061 Phase I Bioavailability Study in Healthy Volunteers).
Investigational
Matched Description: … Study in Healthy Volunteers). ... Vobarilizumab is under investigation in clinical trial NCT02101073 (ALX-0061 Phase I Bioavailability …
Mureletecan
Mureletecan is under investigation in clinical trial NCT00004076 (PNU 166148 in Treating Patients With Metastatic Solid Tumors).
Investigational
Matched Description: … Mureletecan is under investigation in clinical trial NCT00004076 (PNU 166148 in Treating Patients With …
Hydrogen
Hydrogen is under investigation in clinical trial NCT02830854 (Molecular Hydrogen for Cognitive Function and Performance in Elderly).
Investigational
Matched Description: … and Performance in Elderly). ... Hydrogen is under investigation in clinical trial NCT02830854 (Molecular Hydrogen for Cognitive Function …
Futuximab
Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid Tumors).
Investigational
Matched Description: … Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid …
DAS-181
DAS-181 is under investigation in clinical trial NCT00527865 (Single Dose Escalating Study of DAS181 in Adults).
Investigational
Matched Description: … in Adults). ... DAS-181 is under investigation in clinical trial NCT00527865 (Single Dose Escalating Study of DAS181 …
Drinabant
AVE-1625 is an oral selective and potent antagonist of cannabinoid 1 (CB1) receptors having the same mechanism of action as rimonabant. It is currently developed in obesity and its associated comorbidities. AVE-1625 is also being developed for the treatment of Alzheimer disease.
Investigational
Matched Description: … It is currently developed in obesity and its associated comorbidities. …
MVA3000
MVA3000 is an attenuated smallpox vaccine that is being developed for use in people for whom the traditional smallpox vaccine is contraindicated, such as patients with disorders of the immune system or skin conditions such as eczema.
Investigational
Matched Description: … MVA3000 is an attenuated smallpox vaccine that is being developed for use in people for whom the traditional …
R1295
R1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis. Integrins are associated to the pathology seen in some of the autoimmune diseases such as rheumatoid arthritis.
Investigational
Matched Description: … R1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis ... Integrins are associated to the pathology seen in some of the autoimmune diseases such as rheumatoid …
PBT-1033
Investigational
Rabeximod
Rabeximod is an orally administered compound for treatment of moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in eight European countries.
Investigational
Matched Description: … moderate or severe active rheumatoid arthritis that is currently undergoing phase II clinical testing in …
Ganstigmine
Ganstigmine is an orally active, geneserine derived, carbamate-based acetylcholinesterase inhibitor developed for the treatment of Alzheimer's disease.
Investigational
Quarfloxin
Investigational
Molybdenum cofactor
Absence of molybdenum cofactor leads to accumulation of toxic levels of sulphite and neurological damage usually leading to death within months of birth, due to the lack of active sulfite oxidase.
Experimental
Matched Iupac: … [(5aR,8R,9aR)-2-amino-4-oxo-8-[(phosphonatooxy)methyl]-6-sulfanidyl-3H,4H,5H,5aH,8H,9aH,10H-pyrano[3,2 …
Evodenoson
Evodenoson has been used in trials studying the treatment of Open-angle Glaucoma and Ocular Hypertension.
Investigational
Matched Iupac: … methyl 4-(3-{6-amino-9-[(2R,3R,4S,5S)-5-(cyclopropylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]-9H-purin-2-yl …
Matched Description: … Evodenoson has been used in trials studying the treatment of Open-angle Glaucoma and Ocular Hypertension …
Matched Description: … Evodenoson has been used in trials studying the treatment of Open-angle Glaucoma and Ocular Hypertension …
PRI-724
PRI-724 is under investigation in clinical trial NCT03620474 (Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis).
Investigational
Matched Iupac: … (4-{[(6S,9S,9aS)-1-(benzylcarbamoyl)-2,9-dimethyl-4,7-dioxo-8-[(quinolin-8-yl)methyl]-octahydro-1H-pyrazino …
Matched Description: … PRI-724 is under investigation in clinical trial NCT03620474 (Safety and Effectiveness of PRI-724 for …
Matched Description: … PRI-724 is under investigation in clinical trial NCT03620474 (Safety and Effectiveness of PRI-724 for …
Displaying drugs 14601 - 14625 of 15249 in total